{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:34:29Z","timestamp":1787002469319,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/mp.2016.148","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T04:04:44Z","timestamp":1473739484000},"page":"711-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann\u2013Pick disease"],"prefix":"10.1038","volume":"22","author":[{"given":"A","family":"P\u00e9rez-Ca\u00f1am\u00e1s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Benvegn\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C B","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"R\u00e1bano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Satr\u00fastegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"key":"BFmp2016148_CR1","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/B978-0-444-59565-2.00041-1","volume":"113","author":"MT Vanier","year":"2013","unstructured":"Vanier MT . Niemann\u2013Pick diseases. Handb Clin Neurol 2013; 113: 1717\u20131721.","journal-title":"Handb Clin Neurol"},{"key":"BFmp2016148_CR2","first-page":"3589","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"EH Schuchman","year":"2001","unstructured":"Schuchman EH, Desnick RJ . Niemann\u2013Pick disease types A and B: acid sphingomyelinase deficiencies. In: Scriver CR et al (eds). The Metabolic and Molecular Bases of Inherited Disease, vol. II. McGraw-Hill: New York, NY, USA, 2001, p. 3589."},{"key":"BFmp2016148_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1073\/pnas.55.2.366","volume":"55","author":"RO Brady","year":"1996","unstructured":"Brady RO, Kanfer JN, Mock MB, Fredrickson DS . The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann\u2013Pick disease. Proc Natl Acad Sci USA 1996; 55: 366\u2013369.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2016148_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","volume":"6","author":"MC Patterson","year":"2007","unstructured":"Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE . Miglustat for treatment of Niemann\u2013Pick C disease: a randomised controlled study. Lancet Neurol 2007; 6: 765\u2013772.","journal-title":"Lancet Neurol"},{"key":"BFmp2016148_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ymgme.2015.05.013","volume":"116","author":"MP Wasserstein","year":"2015","unstructured":"Wasserstein MP, Jones SA, Soran H, Diaz GA, Lippa N, Thurberg BL et al. Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency. Mol Genet Metab 2015; 116: 88\u201397.","journal-title":"Mol Genet Metab"},{"key":"BFmp2016148_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0009-3084(99)00079-1","volume":"102","author":"W Stoffel","year":"1999","unstructured":"Stoffel W . Functional analysis of acid and neutral sphingomyelinases in vitro and in vivo. Chem Phys Lipids 1999; 102: 107\u2013121.","journal-title":"Chem Phys Lipids"},{"key":"BFmp2016148_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nrm1423","volume":"5","author":"AH Futerman","year":"2004","unstructured":"Futerman AH, van Meer G . The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol 2004; 5: 554\u2013565.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFmp2016148_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/cdd.2014.4","volume":"21","author":"E Gaband\u00e9-Rodr\u00edguez","year":"2014","unstructured":"Gaband\u00e9-Rodr\u00edguez E, Boya P, Labrador V, Dotti CG, Ledesma MD . High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A. Cell Death Differ 2014; 21: 864\u2013875.","journal-title":"Cell Death Differ"},{"key":"BFmp2016148_CR9","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1083\/jcb.201003053","volume":"189","author":"C Tam","year":"2010","unstructured":"Tam C, Idone V, Devlin C, Fernandes MC, Flannery A, He X et al. Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair. J Cell Biol 2010; 189: 1027\u20131038.","journal-title":"J Cell Biol"},{"key":"BFmp2016148_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ng0795-288","volume":"10","author":"K Horinouchi","year":"1995","unstructured":"Horinouchi K, Erlich S, Perl DP, Ferlinz K, Bisgaier CL, Sandhoff K et al. Acid sphingomyelinase deficient mice: a model of types A and B Niemann\u2013Pick disease. Nat Genet 1995; 10: 288\u2013293.","journal-title":"Nat Genet"},{"key":"BFmp2016148_CR11","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nm.3214","volume":"19","author":"E Gulbins","year":"2013","unstructured":"Gulbins E, Palmada M, Reichel M, L\u00fcth A, B\u00f6hmer C, Amato D et al. Acid-sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med 2013; 19: 934\u2013941.","journal-title":"Nat Med"},{"key":"BFmp2016148_CR12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/emmm.201302649","volume":"6","author":"AI Arroyo","year":"2014","unstructured":"Arroyo AI, Camoletto PG, Morando L, Sassoe-Pognetto M, Giustetto M, Van Veldhoven PP et al. Pharmacological reversion of sphingomyelin-induced dendritic spine anomalies in a Niemann Pick disease type A mouse model. EMBO Mol Med 2014; 6: 398\u2013413.","journal-title":"EMBO Mol Med"},{"key":"BFmp2016148_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2014.09.008","volume":"73","author":"L Trov\u00f2","year":"2015","unstructured":"Trov\u00f2 L, Stroobants S, D'Hooge R, Ledesma MD, Dotti CG . Improvement of biochemical and behavioral defects in the Niemann\u2013Pick type A mouse by intraventricular infusion of MARCKS. Neurobiol Dis 2015; 73: 319\u2013326.","journal-title":"Neurobiol Dis"},{"key":"BFmp2016148_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1091\/mbc.e07-05-0439","volume":"19","author":"C Galvan","year":"2008","unstructured":"Galvan C, Camoletto PG, Cristofani F, Van Veldhoven PP, Ledesma MD . Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase. Mol Biol Cell 2008; 19: 509\u2013522.","journal-title":"Mol Biol Cell"},{"key":"BFmp2016148_CR15","doi-asserted-by":"publisher","first-page":"e5310","DOI":"10.1371\/journal.pone.0005310","volume":"4","author":"PG Camoletto","year":"2009","unstructured":"Camoletto PG, Vara H, Morando L, Connell E, Marletto FP et al. Synaptic vesicle docking: sphingosine regulates syntaxin1 interaction with Munc18. PLoS One 2009; 4: e5310.","journal-title":"PLoS One"},{"key":"BFmp2016148_CR16","doi-asserted-by":"publisher","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","volume":"285","author":"EB Vitner","year":"2010","unstructured":"Vitner EB, Platt FM, Futerman AH . Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem 2010; 285: 20423\u201320427.","journal-title":"J Biol Chem"},{"key":"BFmp2016148_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/hmg\/ddm324","volume":"17","author":"H Wei","year":"2008","unstructured":"Wei H, Kim SJ, Zhang Z, Tsai PC, Wisniewski KE, Mukherjee AB . ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Hum Mol Genet 2008; 17: 469\u2013477.","journal-title":"Hum Mol Genet"},{"key":"BFmp2016148_CR18","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","volume":"260","author":"G Grynkiewicz","year":"1985","unstructured":"Grynkiewicz G, Poenie M, Tsien RY . A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440\u20133450.","journal-title":"J Biol Chem"},{"key":"BFmp2016148_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1471-4159.2005.03401.x","volume":"95","author":"MR Sep\u00falveda","year":"2005","unstructured":"Sep\u00falveda MR, Hidalgo-S\u00e1nchez M, Mata AM . A developmental profile of the levels of calcium pumps in chick cerebellum. J Neurochem 2005; 95: 673\u2013683.","journal-title":"J Neurochem"},{"key":"BFmp2016148_CR20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1152\/ajpcell.2001.280.4.C1027","volume":"280","author":"J Chaudhary","year":"2001","unstructured":"Chaudhary J, Walia M, Matharu J, Escher E, Grover AK . Caloxin: a novel plasma membrane Ca2+ pump inhibitor. Am J Physiol Cell Physiol 2001; 280: 1027\u20131030.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFmp2016148_CR21","doi-asserted-by":"publisher","first-page":"34308","DOI":"10.1074\/jbc.M114.586966","volume":"289","author":"J de Juan-Sanz","year":"2014","unstructured":"de Juan-Sanz J, N\u00fa\u00f1ez E, Zafra F, Berrocal M, Corbacho I, Ib\u00e1\u00f1ez I et al. Presynaptic control of glycine transporter 2 (GlyT2) by physical and functional association with plasma membrane Ca2+-ATPase (PMCA) and Na+-Ca2+ exchanger (NCX). J Biol Chem 2014; 289: 34308\u201334324.","journal-title":"J Biol Chem"},{"key":"BFmp2016148_CR22","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1073\/pnas.0437870100","volume":"100","author":"E Hockly","year":"2003","unstructured":"Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci USA 2003; 100: 2041\u20132046.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2016148_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1471-4159.2009.06465.x","volume":"112","author":"GP Cognato","year":"2010","unstructured":"Cognato GP, Agostinho PM, Hockemeyer J, M\u00fcller CE, Souza DO, Cunha RA . Caffeine and an adenosine A(2\u2009A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life. J Neurochem 2010; 112: 453\u2013462.","journal-title":"J Neurochem"},{"key":"BFmp2016148_CR24","first-page":"17","volume":"266","author":"RS Sohal","year":"1989","unstructured":"Sohal RS, Brunk UT . Lipofuscin as an indicator of oxidative stress and aging. Adv Exp Med Biol 1989; 266: 17\u201326.","journal-title":"Adv Exp Med Biol"},{"key":"BFmp2016148_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0891-5849(00)00172-6","volume":"28","author":"F Cardozo-Pelaez","year":"2000","unstructured":"Cardozo-Pelaez F, Brooks PJ, Stedeford T, Song S, Sanchez-Ramos J . DNA damage, repair, and antioxidant systems in brain regions: a correlative study. Free Radic Biol Med 2000; 28: 779\u2013785.","journal-title":"Free Radic Biol Med"},{"key":"BFmp2016148_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/A:1022501702403","volume":"24","author":"C Rodriguez-Lafrasse","year":"1999","unstructured":"Rodriguez-Lafrasse C, Vanier MT . Sphingosylphosphorylcholine in Niemann\u2013Pick disease brain: accumulation in type A but not in type B. Neurochem Res 1999; 24: 199\u2013205.","journal-title":"Neurochem Res"},{"key":"BFmp2016148_CR27","doi-asserted-by":"publisher","first-page":"41128","DOI":"10.1074\/jbc.M206747200","volume":"277","author":"C Luberto","year":"2002","unstructured":"Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, Boros E et al. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 2002; 277: 41128\u201341139.","journal-title":"J Biol Chem"},{"key":"BFmp2016148_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccr.2013.08.003","volume":"24","author":"NH Petersen","year":"2013","unstructured":"Petersen NH, Olsen OD, Groth-Pedersen L, Ellegaard AM, Bilgin M, Redmer S et al. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell 2013; 24: 379\u2013393.","journal-title":"Cancer Cell"},{"key":"BFmp2016148_CR29","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1093\/hmg\/ddu155","volume":"23","author":"A Franco-Villanueva","year":"2014","unstructured":"Franco-Villanueva A, Fern\u00e1ndez-L\u00f3pez E, Gaband\u00e9-Rodr\u00edguez E, Ba\u00f1\u00f3n-Rodr\u00edguez I, Esteban JA, Ant\u00f3n IM et al. WIP modulates dendritic spine actin cytoskeleton by transcriptional control of lipid metabolic enzymes. Hum Mol Genet 2014; 23: 4383\u20134395.","journal-title":"Hum Mol Genet"},{"key":"BFmp2016148_CR30","first-page":"12","volume":"2","author":"X Wang","year":"2010","unstructured":"Wang X, Michaelis EK . Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci 2010; 2: 12.","journal-title":"Front Aging Neurosci"},{"key":"BFmp2016148_CR31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/ars.2010.3386","volume":"14","author":"M Gleichmann","year":"2011","unstructured":"Gleichmann M, Mattson MP . Neuronal calcium homeostasis and dysregulation. Antioxid Redox Signal 2011; 14: 1261\u20131273.","journal-title":"Antioxid Redox Signal"},{"key":"BFmp2016148_CR32","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1152\/jn.1994.72.4.1973","volume":"72","author":"M Tymianski","year":"1994","unstructured":"Tymianski M, Charlton MP, Carlen PL, Tator CH . Properties of neuroprotective cell-permeant Ca2+ chelators: effects on [Ca2+]i and glutamate neurotoxicity in vitro. J Neurophysiol 1994; 72: 1973\u20131992.","journal-title":"J Neurophysiol"},{"key":"BFmp2016148_CR33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/ncomms1735","volume":"3","author":"D Shen","year":"2012","unstructured":"Shen D, Wang X, Li X, Zhang X, Yao Z, Dibble S et al. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat Commun 2012; 3: 731.","journal-title":"Nat Commun"},{"key":"BFmp2016148_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1152\/physrev.1994.74.3.595","volume":"74","author":"T Pozzan","year":"1994","unstructured":"Pozzan T, Rizzuto R, Volpe P, Meldolesi J . Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 1994; 74: 595\u2013636.","journal-title":"Physiol Rev"},{"key":"BFmp2016148_CR35","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/j.1471-4159.2005.03534.x","volume":"95","author":"L Ginzburg","year":"2005","unstructured":"Ginzburg L, Futerman AH . Defective calcium homeostasis in the cerebellum in a mouse model of Niemann\u2013Pick A disease. J Neurochem 2005; 95: 1619\u20131628.","journal-title":"J Neurochem"},{"key":"BFmp2016148_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1023\/A:1009210001608","volume":"11","author":"D Guerini","year":"1998","unstructured":"Guerini D . The Ca2+ pumps and the Na+\/Ca2+ exchangers. Biometals 1998; 11: 319\u2013330.","journal-title":"Biometals"},{"key":"BFmp2016148_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1196\/annals.1387.023","volume":"1099","author":"EE Strehler","year":"2007","unstructured":"Strehler EE, Caride AJ, Filoteo AG, Xiong Y, Penniston JT, Enyedi A . Plasma membrane Ca2+-ATPases as dynamic regulators of cellular calcium handling. Ann N Y Acad Sci 2007; 1099: 226\u2013236.","journal-title":"Ann N Y Acad Sci"},{"key":"BFmp2016148_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1471-4159.2012.07918.x","volume":"123","author":"L Jiang","year":"2012","unstructured":"Jiang L, Bechtel MD, Galeva NA, Williams TD, Michaelis EK, Michaelis ML . Decreases in plasma membrane Ca2+-ATPase in brain synaptic membrane rafts from aged rats. J Neurochem 2012; 123: 689\u2013699.","journal-title":"J Neurochem"},{"key":"BFmp2016148_CR39","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.febslet.2005.03.038","volume":"579","author":"Y Pang","year":"2005","unstructured":"Pang Y, Zhu H, Wu P, Chen J . The characterization of plasma membrane Ca2+-ATPase in rich sphingomyelin-cholesterol domains. FEBS Lett 2005; 579: 2397\u20132403.","journal-title":"FEBS Lett"},{"key":"BFmp2016148_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ceca.2013.12.003","volume":"55","author":"K Varga","year":"2014","unstructured":"Varga K, P\u00e1szty K, Pad\u00e1nyi R, Heged\u0171s L, Brouland JP, Papp B et al. Histone deacetylase inhibitor- and PMA-induced upregulation of PMCA4b enhances Ca2+ clearance from MCF-7 breast cancer cells. Cell Calcium 2014; 55: 78\u201392.","journal-title":"Cell Calcium"},{"key":"BFmp2016148_CR41","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1172\/JCI64503","volume":"123","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Ashlock BM, Toomey NL, Diaz LA, Mesri EA, Lossos IS et al. Efficacious proteasome\/HDAC inhibitor combination therapy for primary effusion lymphoma. J Clin Invest 2013; 123: 2616\u20132628.","journal-title":"J Clin Invest"},{"key":"BFmp2016148_CR42","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1046\/j.0953-816x.2001.01564.x","volume":"13","author":"J Sarna","year":"2001","unstructured":"Sarna J, Miranda SR, Schuchman EH, Hawkes R . Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A\/B disease. Eur J Neurosci 2001; 13: 1873\u20131880.","journal-title":"Eur J Neurosci"},{"key":"BFmp2016148_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.expneurol.2008.07.026","volume":"214","author":"SL Macauley","year":"2008","unstructured":"Macauley SL, Sidman RL, Schuchman EH, Taksir T, Stewart GR . Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann\u2013Pick A disease including structure\u2013function studies associated with cerebellar Purkinje cell degeneration. Exp Neurol 2008; 214: 181\u2013192.","journal-title":"Exp Neurol"},{"key":"BFmp2016148_CR44","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/emboj\/18.7.1761","volume":"18","author":"MD Ledesma","year":"1999","unstructured":"Ledesma MD, Br\u00fcgger B, B\u00fcnning C, Wieland FT, Dotti CG . Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes. EMBO J 1999; 18: 1761\u20131771.","journal-title":"EMBO J"},{"key":"BFmp2016148_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12013-012-9467-6","volume":"66","author":"L Vanagas","year":"2013","unstructured":"Vanagas L, de La Fuente MC, Dalghi M, Ferreira-Gomes M, Rossi RC, Strehler EE et al. Differential effects of G- and F-actin on the plasma membrane calcium pump activity. Cell Biochem Biophys 2013; 66: 187\u2013198.","journal-title":"Cell Biochem Biophys"},{"key":"BFmp2016148_CR46","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0891-5849(99)00128-8","volume":"27","author":"A Zaidi","year":"1999","unstructured":"Zaidi A, Michaelis ML . Effects of reactive oxygen species on brain synaptic plasma membrane Ca2+-ATPase. Free Radic Biol Med 1999; 27: 810\u2013821.","journal-title":"Free Radic Biol Med"},{"key":"BFmp2016148_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm1155","volume":"4","author":"MJ Berridge","year":"2003","unstructured":"Berridge MJ, Bootman MD, Roderick HL . Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4: 517\u2013529.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFmp2016148_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00424-008-0505-6","volume":"457","author":"M Brini","year":"2009","unstructured":"Brini M . Plasma membrane Ca2+-ATPase: from a housekeeping function to a versatile signaling role. Pflugers Arch 2009; 457: 657\u2013664.","journal-title":"Pflugers Arch"},{"key":"BFmp2016148_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/bs.mcb.2014.11.009","volume":"126","author":"M Corrotte","year":"2015","unstructured":"Corrotte M, Castro-Gomes T, Koushik AB, Andrews NW . Approaches for plasma membrane wounding and assessment of lysosome-mediated repair responses. Methods Cell Biol 2015; 126: 139\u2013158.","journal-title":"Methods Cell Biol"},{"key":"BFmp2016148_CR50","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1083\/jcb.200708010","volume":"180","author":"V Idone","year":"2008","unstructured":"Idone V, Tam C, Goss JW, Toomre D, Pypaert M, Andrews NW . Repair of injured plasma membrane by rapid Ca2+-dependent endocytosis. J Cell Biol. 2008; 180: 905\u2013914.","journal-title":"J Cell Biol."},{"key":"BFmp2016148_CR51","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1212\/01.wnl.0000194208.08904.0c","volume":"66","author":"MM McGovern","year":"2006","unstructured":"McGovern MM, Aron A, Brodie SE, Desnick RJ, Wasserstein MP . Natural history of Type A Niemann\u2013Pick disease: possible endpoints for therapeutic trials. Neurology 2006; 66: 228\u2013232.","journal-title":"Neurology"},{"key":"BFmp2016148_CR52","doi-asserted-by":"publisher","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","volume":"274","author":"E Korkotian","year":"1999","unstructured":"Korkotian E, Schwarz A, Pelled D, Schwarzmann G, Segal M, Futerman AH . Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J Biol Chem 1999; 274: 21673\u201321678.","journal-title":"J Biol Chem"},{"key":"BFmp2016148_CR53","doi-asserted-by":"publisher","first-page":"23594","DOI":"10.1074\/jbc.M300212200","volume":"278","author":"E Lloyd-Evans","year":"2003","unstructured":"Lloyd-Evans E, Pelled D, Riebeling C, Bodennec J, de-Morgan A, Waller H et al. Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J Biol Chem 2003; 278: 23594\u201323599.","journal-title":"J Biol Chem"},{"key":"BFmp2016148_CR54","doi-asserted-by":"publisher","first-page":"29496","DOI":"10.1074\/jbc.M302964200","volume":"278","author":"D Pelled","year":"2003","unstructured":"Pelled D, Lloyd-Evans E, Riebeling C, Jeyakumar M, Platt FM, Futerman AH . Inhibition of calcium uptake via the sarco\/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. J Biol Chem 2003; 278: 29496\u201329501.","journal-title":"J Biol Chem"},{"key":"BFmp2016148_CR55","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.molcel.2009.10.021","volume":"36","author":"R Sano","year":"2009","unstructured":"Sano R, Annunziata I, Patterson A, Moshiach S, Gomero E, Opferman J et al. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca2+-dependent mitochondrial apoptosis. Mol Cell 2009; 36: 500\u2013511.","journal-title":"Mol Cell"},{"key":"BFmp2016148_CR56","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nm.1876","volume":"14","author":"E Lloyd-Evans","year":"2008","unstructured":"Lloyd-Evans E, Morgan AJ, He X, Smith DA, Elliot-Smith E, Sillence DJ et al. Niemann\u2013Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med 2008; 14: 1247\u20131255.","journal-title":"Nat Med"},{"key":"BFmp2016148_CR57","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1073\/pnas.1014890108","volume":"108","author":"NH Pipalia","year":"2011","unstructured":"Pipalia NH, Cosner CC, Huang A, Chatterjee A, Bourbon P, Farley N et al. Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann\u2013Pick type C1 mutant human fibroblasts. Proc Natl Acad Sci USA 2011; 108: 5620\u20135625.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2016148_CR58","doi-asserted-by":"publisher","first-page":"23842","DOI":"10.1074\/jbc.M111.227645","volume":"286","author":"AB Munkacsi","year":"2011","unstructured":"Munkacsi AB, Chen FW, Brinkman MA, Higaki K, Guti\u00e9rrez GD, Chaudhari J et al. An \"exacerbate-reverse\" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann\u2013Pick type C disease. J Biol Chem 2011; 286: 23842\u201323851.","journal-title":"J Biol Chem"},{"key":"BFmp2016148_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature07925","volume":"459","author":"JS Guan","year":"2009","unstructured":"Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009; 459: 55\u201360.","journal-title":"Nature"},{"key":"BFmp2016148_CR60","doi-asserted-by":"publisher","first-page":"e69964","DOI":"10.1371\/journal.pone.0069964","volume":"8","author":"JE Hanson","year":"2013","unstructured":"Hanson JE, La H, Plise E, Chen YH, Ding X, Hanania T et al. SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition. PLoS One 2013; 8: e69964.","journal-title":"PLoS One"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2016148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2016148","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2016.148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/mp2016148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:45:02Z","timestamp":1648766702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2016148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFmp2016148"],"URL":"https:\/\/doi.org\/10.1038\/mp.2016.148","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]},"assertion":[{"value":"1 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}